MorphoSys AG
XETRA:MOR
MorphoSys AG
XETRA:MOR
Price:
66.65 EUR
0.83%
Market Closed
Updated:
May 3, 2024
MorphoSys AG
Cash from Investing Activities
|
MorphoSys AG
Cash from Investing Activities Peer Comparison
Comparables:
BNTX
CVAC
IMTX
BIO
FYB
Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Investing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
MorphoSys AG
XETRA:MOR
|
Cash from Investing Activities
€15.4m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
BioNTech SE
NASDAQ:BNTX
|
Cash from Investing Activities
-€7B
|
CAGR 3-Years
-263%
|
CAGR 5-Years
-154%
|
CAGR 10-Years
N/A
|
|
|
CureVac NV
NASDAQ:CVAC
|
Cash from Investing Activities
-€55.2m
|
CAGR 3-Years
-7%
|
CAGR 5-Years
-67%
|
CAGR 10-Years
N/A
|
|
|
Immatics NV
NASDAQ:IMTX
|
Cash from Investing Activities
-€31.4m
|
CAGR 3-Years
-25%
|
CAGR 5-Years
-18%
|
CAGR 10-Years
N/A
|
|
|
Biotest AG
XETRA:BIO
|
Cash from Investing Activities
€1.3m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-64%
|
CAGR 10-Years
N/A
|
|
|
Formycon AG
XETRA:FYB
|
Cash from Investing Activities
-€37.1m
|
CAGR 3-Years
-87%
|
CAGR 5-Years
-136%
|
CAGR 10-Years
N/A
|
See Also
What is MorphoSys AG's Cash from Investing Activities?
Cash from Investing Activities
15.4m
EUR
15.4m
EUR
Based on the financial report for Dec 31, 2023, MorphoSys AG's Cash from Investing Activities amounts to 15.4m EUR.
What is MorphoSys AG's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 1Y
-96%
-96%
Over the last year, the Cash from Investing Activities growth was -96%.
You don't have any saved screeners yet
